Progress in understanding the biology of nodular lymphocyte predominant Hodgkin lymphoma von Straus, David J

Volltext

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology... von Press, Oliver W, Li, Hongli, Schöder, Heiko, Straus, David J, Moskowitz, Craig H, LeBlanc, Michael, Rimsza, Lisa M, Bartlett, Nancy L, Evens, Andrew M, Mittra, Erik S, LaCasce, Ann S, Sweetenham, John W, Barr, Paul M, Fanale, Michelle A, Knopp, Michael V, Noy, Ariela, Hsi, Eric D, Cook, James R, Lechowicz, Mary Jo, Gascoyne, Randy D, Leonard, John P, Kahl, Brad S, Cheson, Bruce D, Fisher, Richard I, Friedberg, Jonathan W

Volltext

CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET von Straus, David J., Jung, Sin-Ho, Pitcher, Brandelyn, Kostakoglu, Lale, Grecula, John C., Hsi, Eric D., Schöder, Heiko, Popplewell, Leslie L., Chang, Julie E., Moskowitz, Craig H., Wagner-Johnston, Nina, Leonard, John P., Friedberg, Jonathan W., Kahl, Brad S., Cheson, Bruce D., Bartlett, Nancy L.

Volltext

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma von MOSKOWITZ, Alison J, HAMLIN, Paul A, GRAUSTEIN, Tricia, ZELENETZ, Andrew D, MOSKOWITZ, Craig H, PERALES, Miguel-Angel, GERECITANO, John, HORWITZ, Steven M, MATASAR, Matthew J, NOY, Ariela, LIA PALOMBA, Maria, PORTLOCK, Carol S, STRAUS, David J

Volltext

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1 von Crosswell, Howland E, LaCasce, Ann S, Bartlett, Nancy L, Straus, David J, Savage, Kerry J, Zinzani, Pier Luigi, Collins, Graham P, Fanale, Michelle, Fenton, Keenan, Dong, Cassie, Miao, Harry, Grigg, Andrew P

Volltext

Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation von Epstein-Peterson, Zachary D, Drill, Esther, Aypar, Umut, Batlevi, Connie Lee, Caron, Philip, Dogan, Ahmet, Drullinsky, Pamela, Gerecitano, John, Hamlin, Paul A, Ho, Caleb, Jacob, Allison, Joseph, Ashlee, Laraque, Leana, Matasar, Matthew J, Moskowitz, Alison J, Moskowitz, Craig H, Mullins, Chelsea, Owens, Colette, Salles, Gilles, Schöder, Heiko, Straus, David J, Younes, Anas, Zelenetz, Andrew D, Kumar, Anita

Volltext

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation von Epstein-Peterson, Zachary D, Drill, Esther, Aypar, Umut, Batlevi, Connie Lee, Caron, Philip, Dogan, Ahmet, Drullinsky, Pamela, Gerecitano, John, Hamlin, Paul A, Ho, Caleb, Jacob, Allison, Joseph, Ashlee, Laraque, Leana, Matasar, Matthew J, Moskowitz, Alison J, Moskowitz, Craig H, Mullins, Chelsea, Owens, Colette, Salles, Gilles, Schöder, Heiko, Straus, David J, Younes, Anas, Zelenetz, Andrew D, Kumar, Anita

Volltext

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I,... von Straus, David J., Portlock, Carol S., Qin, Jing, Myers, Jane, Zelenetz, Andrew D., Moskowitz, Craig, Noy, Ariela, Goy, André, Yahalom, Joachim

Volltext

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma von Connors, Joseph M, Jurczak, Wojciech, Straus, David J, Ansell, Stephen M, Kim, Won S, Gallamini, Andrea, Younes, Anas, Alekseev, Sergey, Illés, Árpád, Picardi, Marco, Lech-Maranda, Ewa, Oki, Yasuhiro, Feldman, Tatyana, Smolewski, Piotr, Savage, Kerry J, Bartlett, Nancy L, Walewski, Jan, Chen, Robert, Ramchandren, Radhakrishnan, Zinzani, Pier L, Cunningham, David, Rosta, Andras, Josephson, Neil C, Song, Eric, Sachs, Jessica, Liu, Rachael, Jolin, Hina A, Huebner, Dirk, Radford, John

Volltext

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma von Ansell, Stephen M., Radford, John, Connors, Joseph M., Długosz-Danecka, Monika, Kim, Won-Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Hutchings, Martin, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J.

Volltext

Acupuncture for Postchemotherapy Fatigue: A Phase II Study von VICKERS, Andrew J, STRAUS, David J, FEARON, Bertha, CASSILETH, Barrie R

Volltext

Initial Hodgkin treatment of the frail elderly von Straus, David J.

Volltext

The Treatment of Non-Hodgkin's Lymphomas von Straus, David J.

Volltext

Treatment of Newly Diagnosed Classical Hodgkin Lymphoma von Straus, David J.

Volltext

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma von Moskowitz, Alison J, Shah, Gunjan, Schöder, Heiko, Ganesan, Nivetha, Drill, Esther, Hancock, Helen, Davey, Theresa, Perez, Leslie, Ryu, Sunyoung, Sohail, Samia, Santarosa, Alayna, Galasso, Natasha, Neuman, Rachel, Liotta, Brielle, Blouin, William, Kumar, Anita, Lahoud, Oscar, Batlevi, Connie L, Hamlin, Paul, Straus, David J, Rodriguez-Rivera, Ildefonso, Owens, Colette, Caron, Philip, Intlekofer, Andrew M, Hamilton, Audrey, Horwitz, Steven M, Falchi, Lorenzo, Joffe, Erel, Johnson, William, Lee, Christina, Palomba, M Lia, Noy, Ariela, Matasar, Matthew J, Pongas, Georgios, Salles, Gilles, Vardhana, Santosha, Sanin, Beatriz Wills, von Keudell, Gottfried, Yahalom, Joachim, Dogan, Ahmet, Zelenetz, Andrew D, Moskowitz, Craig H

Volltext

Next Questions – Classical Hodgkin Lymphoma (cHL) von Straus, David J.

Volltext

Limited-Stage Hodgkin Lymphoma: Minimizing Toxicity von Straus, David J

Volltext

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study von Straus, David J., Długosz-Danecka, Monika, Alekseev, Sergey, Illés, Árpád, Picardi, Marco, Lech-Maranda, Ewa, Feldman, Tatyana, Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Walewski, Jan, Ramchandren, Radhakrishnan, Zinzani, Pier Luigi, Hutchings, Martin, Connors, Joseph M., Radford, John, Munoz, Javier, Kim, Won Seog, Advani, Ranjana, Ansell, Stephen M., Younes, Anas, Miao, Harry, Liu, Rachael, Fenton, Keenan, Forero-Torres, Andres, Gallamini, Andrea

Volltext

Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma von Stephens, Deborah M., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., LaCasce, Ann S., Barr, Paul M., Knopp, Michael V., Hsi, Eric D., Leonard, John P., Kahl, Brad S., Smith, Sonali M., Friedberg, Jonathan W.

Volltext

Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary von Straus, David J

Volltext